Pectusin (Pectusin)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceEucalyptus leaf-shaped oil + [Racetenol]Eucalyptus leaf-shaped oil + [Racetenol]
Similar drugsTo uncover
  • Pectusin
    pills locally 
    VIFITEH, CJSC     Russia
  • Evamenol®
    ointment nazal. 
    MOSCOW PHARMACEUTICAL FACTORY, CJSC     Russia
    • Dosage form: & nbsp
    Lozenges
    Composition:

    Active components

    L-menthol (levomenthol) -0.0040 g

    Eucalyptus oil -0,0005 g

    Auxiliary substances

    Sugar powder (sucrose) -0.6745 g

    Cellulose microcrystalline-0.0799 g

    Sodium salt carboxymethyl cellulose (carmellose sodium) -0.0134 g

    Talcum -0.0200 g

    Calcium stearate -0.0077 g

    Weight of a tablet -0.8000 g

    Description:

    Tablets are round, flat-cylindrical with a facet and a risk, from white to white with a yellowish tint of color with a specific odor. On the surface of the tablets, darker and lighter blotches are allowed.

    Pharmacotherapeutic group:Antimicrobial agent of plant origin.
    ATX: & nbsp

    R.07.A.X   Other preparations for the treatment of respiratory diseases

    Pharmacodynamics:

    Has a weak antimicrobial and anti-inflammatory effect.

    Indications:

    Applied in the complex therapy of inflammatory diseases of the upper respiratory tract.

    Contraindications:

    Hypersensitivity to the components of the drug. Children up to 8 years. Deficiency of sugar / isomaltase, intolerance to fructose,glucose-galactose malabsorption.

    Carefully:

    Diabetes mellitus, pregnancy, the period of breastfeeding

    Dosing and Administration:

    Locally. Tablets should be kept in the mouth until completely absorbed, not chewing. Adults - 1 tablet 3-4 times a day; children older than 8 years - 1-2 tablets a day. Duration of treatment 5 days.

    Side effects:

    Allergic reactions are possible

    Overdose:

    So far, there have been no cases of overdose.

    Interaction with other drugs Not described.

    Special instructions:

    In one tablet of the drug contains about 0.75 g of carbohydrates, which corresponds to 0.06 XE.

    Form release / dosage:Lozenges.
    Packaging:For 10 tablets in a planar cell package. 2, 3 or 5 contour mesh packages together with instructions for use in a pack of cardboard. 200 contour mesh packages together with an equal number of instructions for use in a cardboard box box or in a box of corrugated cardboard.
    Storage conditions:

    In a dry place at a temperature of no higher than 15 ° C.

    Keep out of the reach of children.

    Shelf life:

    1 year.

    Do not use the drug after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-000164
    Date of registration:13.01.2011
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspVIFITEH, CJSCVIFITEH, CJSC
    Information update date: & nbsp13.01.2011
    Illustrated instructions
      Instructions
      Up